[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Bispecific Antibody Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

September 2023 | 125 pages | ID: G27A17D76B46EN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question


The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Bispecific Antibody market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Key players in the global Bispecific Antibody market are covered in Chapter 9:

Regeneron Pharmaceuticals
Ablynx
MacroGenics
Neovii Biotech
Adimab
Sanofi
Emergent BioSolutions
AstraZeneca (MedImmune)
NovImmune SA
Immunomedics
Roche
EMD Serono
Pieris
OncoMed Pharmaceuticals
Eli Lilly
Jounce Therapeutics
Chugai Pharmaceutical
Merus
Genmab
Amgen
Affimed Therapeutics
Genentech

In Chapter 5 and Chapter 7.3, based on types, the Bispecific Antibody market from 2017 to 2027 is primarily split into:

Mab or Peptide
BiTE
Bispecific mAb
CAR-T
ADC
Small Molecule


In Chapter 6 and Chapter 7.4, based on applications, the Bispecific Antibody market from 2017 to 2027 covers:

Oncology
Solid Tumors
Inflammation
Cardiovascular
General Medicine

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Client Focus

1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Bispecific Antibody market?

Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Bispecific Antibody Industry.

2. How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Please find the key player list in Summary.

3. What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report.

Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?

Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Outline

Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.

Chapter 11 introduces the market research methods and data sources.

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2027

1 BISPECIFIC ANTIBODY MARKET OVERVIEW

1.1 Product Overview and Scope of Bispecific Antibody Market
1.2 Bispecific Antibody Market Segment by Type
  1.2.1 Global Bispecific Antibody Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Bispecific Antibody Market Segment by Application
  1.3.1 Bispecific Antibody Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Bispecific Antibody Market, Region Wise (2017-2027)
  1.4.1 Global Bispecific Antibody Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Bispecific Antibody Market Status and Prospect (2017-2027)
  1.4.3 Europe Bispecific Antibody Market Status and Prospect (2017-2027)
  1.4.4 China Bispecific Antibody Market Status and Prospect (2017-2027)
  1.4.5 Japan Bispecific Antibody Market Status and Prospect (2017-2027)
  1.4.6 India Bispecific Antibody Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Bispecific Antibody Market Status and Prospect (2017-2027)
  1.4.8 Latin America Bispecific Antibody Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Bispecific Antibody Market Status and Prospect (2017-2027)
1.5 Global Market Size of Bispecific Antibody (2017-2027)
  1.5.1 Global Bispecific Antibody Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Bispecific Antibody Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Bispecific Antibody Market

2 INDUSTRY OUTLOOK

2.1 Bispecific Antibody Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Bispecific Antibody Market Drivers Analysis
2.4 Bispecific Antibody Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Bispecific Antibody Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Bispecific Antibody Industry Development

3 GLOBAL BISPECIFIC ANTIBODY MARKET LANDSCAPE BY PLAYER

3.1 Global Bispecific Antibody Sales Volume and Share by Player (2017-2022)
3.2 Global Bispecific Antibody Revenue and Market Share by Player (2017-2022)
3.3 Global Bispecific Antibody Average Price by Player (2017-2022)
3.4 Global Bispecific Antibody Gross Margin by Player (2017-2022)
3.5 Bispecific Antibody Market Competitive Situation and Trends
  3.5.1 Bispecific Antibody Market Concentration Rate
  3.5.2 Bispecific Antibody Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL BISPECIFIC ANTIBODY SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Bispecific Antibody Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Bispecific Antibody Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Bispecific Antibody Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Bispecific Antibody Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Bispecific Antibody Market Under COVID-19
4.5 Europe Bispecific Antibody Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Bispecific Antibody Market Under COVID-19
4.6 China Bispecific Antibody Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Bispecific Antibody Market Under COVID-19
4.7 Japan Bispecific Antibody Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Bispecific Antibody Market Under COVID-19
4.8 India Bispecific Antibody Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Bispecific Antibody Market Under COVID-19
4.9 Southeast Asia Bispecific Antibody Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Bispecific Antibody Market Under COVID-19
4.10 Latin America Bispecific Antibody Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Bispecific Antibody Market Under COVID-19
4.11 Middle East and Africa Bispecific Antibody Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Bispecific Antibody Market Under COVID-19

5 GLOBAL BISPECIFIC ANTIBODY SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Bispecific Antibody Sales Volume and Market Share by Type (2017-2022)
5.2 Global Bispecific Antibody Revenue and Market Share by Type (2017-2022)
5.3 Global Bispecific Antibody Price by Type (2017-2022)
5.4 Global Bispecific Antibody Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Bispecific Antibody Sales Volume, Revenue and Growth Rate of Mab or Peptide (2017-2022)
  5.4.2 Global Bispecific Antibody Sales Volume, Revenue and Growth Rate of BiTE (2017-2022)
  5.4.3 Global Bispecific Antibody Sales Volume, Revenue and Growth Rate of Bispecific mAb (2017-2022)
  5.4.4 Global Bispecific Antibody Sales Volume, Revenue and Growth Rate of CAR-T (2017-2022)
  5.4.5 Global Bispecific Antibody Sales Volume, Revenue and Growth Rate of ADC (2017-2022)
  5.4.6 Global Bispecific Antibody Sales Volume, Revenue and Growth Rate of Small Molecule (2017-2022)

6 GLOBAL BISPECIFIC ANTIBODY MARKET ANALYSIS BY APPLICATION

6.1 Global Bispecific Antibody Consumption and Market Share by Application (2017-2022)
6.2 Global Bispecific Antibody Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Bispecific Antibody Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Bispecific Antibody Consumption and Growth Rate of Oncology (2017-2022)
  6.3.2 Global Bispecific Antibody Consumption and Growth Rate of Solid Tumors (2017-2022)
  6.3.3 Global Bispecific Antibody Consumption and Growth Rate of Inflammation (2017-2022)
  6.3.4 Global Bispecific Antibody Consumption and Growth Rate of Cardiovascular (2017-2022)
  6.3.5 Global Bispecific Antibody Consumption and Growth Rate of General Medicine (2017-2022)

7 GLOBAL BISPECIFIC ANTIBODY MARKET FORECAST (2022-2027)

7.1 Global Bispecific Antibody Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Bispecific Antibody Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Bispecific Antibody Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Bispecific Antibody Price and Trend Forecast (2022-2027)
7.2 Global Bispecific Antibody Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Bispecific Antibody Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Bispecific Antibody Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Bispecific Antibody Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Bispecific Antibody Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Bispecific Antibody Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Bispecific Antibody Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Bispecific Antibody Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Bispecific Antibody Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Bispecific Antibody Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Bispecific Antibody Revenue and Growth Rate of Mab or Peptide (2022-2027)
  7.3.2 Global Bispecific Antibody Revenue and Growth Rate of BiTE (2022-2027)
  7.3.3 Global Bispecific Antibody Revenue and Growth Rate of Bispecific mAb (2022-2027)
  7.3.4 Global Bispecific Antibody Revenue and Growth Rate of CAR-T (2022-2027)
  7.3.5 Global Bispecific Antibody Revenue and Growth Rate of ADC (2022-2027)
  7.3.6 Global Bispecific Antibody Revenue and Growth Rate of Small Molecule (2022-2027)
7.4 Global Bispecific Antibody Consumption Forecast by Application (2022-2027)
  7.4.1 Global Bispecific Antibody Consumption Value and Growth Rate of Oncology(2022-2027)
  7.4.2 Global Bispecific Antibody Consumption Value and Growth Rate of Solid Tumors(2022-2027)
  7.4.3 Global Bispecific Antibody Consumption Value and Growth Rate of Inflammation(2022-2027)
  7.4.4 Global Bispecific Antibody Consumption Value and Growth Rate of Cardiovascular(2022-2027)
  7.4.5 Global Bispecific Antibody Consumption Value and Growth Rate of General Medicine(2022-2027)
7.5 Bispecific Antibody Market Forecast Under COVID-19

8 BISPECIFIC ANTIBODY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Bispecific Antibody Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Bispecific Antibody Analysis
8.6 Major Downstream Buyers of Bispecific Antibody Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Bispecific Antibody Industry

9 PLAYERS PROFILES

9.1 Regeneron Pharmaceuticals
  9.1.1 Regeneron Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Bispecific Antibody Product Profiles, Application and Specification
  9.1.3 Regeneron Pharmaceuticals Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Ablynx
  9.2.1 Ablynx Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Bispecific Antibody Product Profiles, Application and Specification
  9.2.3 Ablynx Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 MacroGenics
  9.3.1 MacroGenics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Bispecific Antibody Product Profiles, Application and Specification
  9.3.3 MacroGenics Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Neovii Biotech
  9.4.1 Neovii Biotech Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Bispecific Antibody Product Profiles, Application and Specification
  9.4.3 Neovii Biotech Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Adimab
  9.5.1 Adimab Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Bispecific Antibody Product Profiles, Application and Specification
  9.5.3 Adimab Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Sanofi
  9.6.1 Sanofi Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Bispecific Antibody Product Profiles, Application and Specification
  9.6.3 Sanofi Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 Emergent BioSolutions
  9.7.1 Emergent BioSolutions Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Bispecific Antibody Product Profiles, Application and Specification
  9.7.3 Emergent BioSolutions Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 AstraZeneca (MedImmune)
  9.8.1 AstraZeneca (MedImmune) Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Bispecific Antibody Product Profiles, Application and Specification
  9.8.3 AstraZeneca (MedImmune) Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 NovImmune SA
  9.9.1 NovImmune SA Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Bispecific Antibody Product Profiles, Application and Specification
  9.9.3 NovImmune SA Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 Immunomedics
  9.10.1 Immunomedics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 Bispecific Antibody Product Profiles, Application and Specification
  9.10.3 Immunomedics Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis
9.11 Roche
  9.11.1 Roche Basic Information, Manufacturing Base, Sales Region and Competitors
  9.11.2 Bispecific Antibody Product Profiles, Application and Specification
  9.11.3 Roche Market Performance (2017-2022)
  9.11.4 Recent Development
  9.11.5 SWOT Analysis
9.12 EMD Serono
  9.12.1 EMD Serono Basic Information, Manufacturing Base, Sales Region and Competitors
  9.12.2 Bispecific Antibody Product Profiles, Application and Specification
  9.12.3 EMD Serono Market Performance (2017-2022)
  9.12.4 Recent Development
  9.12.5 SWOT Analysis
9.13 Pieris
  9.13.1 Pieris Basic Information, Manufacturing Base, Sales Region and Competitors
  9.13.2 Bispecific Antibody Product Profiles, Application and Specification
  9.13.3 Pieris Market Performance (2017-2022)
  9.13.4 Recent Development
  9.13.5 SWOT Analysis
9.14 OncoMed Pharmaceuticals
  9.14.1 OncoMed Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.14.2 Bispecific Antibody Product Profiles, Application and Specification
  9.14.3 OncoMed Pharmaceuticals Market Performance (2017-2022)
  9.14.4 Recent Development
  9.14.5 SWOT Analysis
9.15 Eli Lilly
  9.15.1 Eli Lilly Basic Information, Manufacturing Base, Sales Region and Competitors
  9.15.2 Bispecific Antibody Product Profiles, Application and Specification
  9.15.3 Eli Lilly Market Performance (2017-2022)
  9.15.4 Recent Development
  9.15.5 SWOT Analysis
9.16 Jounce Therapeutics
  9.16.1 Jounce Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.16.2 Bispecific Antibody Product Profiles, Application and Specification
  9.16.3 Jounce Therapeutics Market Performance (2017-2022)
  9.16.4 Recent Development
  9.16.5 SWOT Analysis
9.17 Chugai Pharmaceutical
  9.17.1 Chugai Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
  9.17.2 Bispecific Antibody Product Profiles, Application and Specification
  9.17.3 Chugai Pharmaceutical Market Performance (2017-2022)
  9.17.4 Recent Development
  9.17.5 SWOT Analysis
9.18 Merus
  9.18.1 Merus Basic Information, Manufacturing Base, Sales Region and Competitors
  9.18.2 Bispecific Antibody Product Profiles, Application and Specification
  9.18.3 Merus Market Performance (2017-2022)
  9.18.4 Recent Development
  9.18.5 SWOT Analysis
9.19 Genmab
  9.19.1 Genmab Basic Information, Manufacturing Base, Sales Region and Competitors
  9.19.2 Bispecific Antibody Product Profiles, Application and Specification
  9.19.3 Genmab Market Performance (2017-2022)
  9.19.4 Recent Development
  9.19.5 SWOT Analysis
9.20 Amgen
  9.20.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
  9.20.2 Bispecific Antibody Product Profiles, Application and Specification
  9.20.3 Amgen Market Performance (2017-2022)
  9.20.4 Recent Development
  9.20.5 SWOT Analysis
9.21 Affimed Therapeutics
  9.21.1 Affimed Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.21.2 Bispecific Antibody Product Profiles, Application and Specification
  9.21.3 Affimed Therapeutics Market Performance (2017-2022)
  9.21.4 Recent Development
  9.21.5 SWOT Analysis
9.22 Genentech
  9.22.1 Genentech Basic Information, Manufacturing Base, Sales Region and Competitors
  9.22.2 Bispecific Antibody Product Profiles, Application and Specification
  9.22.3 Genentech Market Performance (2017-2022)
  9.22.4 Recent Development
  9.22.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION


11 APPENDIX

11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES

Figure Bispecific Antibody Product Picture
Table Global Bispecific Antibody Market Sales Volume and CAGR (%) Comparison by Type
Table Bispecific Antibody Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Bispecific Antibody Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Bispecific Antibody Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Bispecific Antibody Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Bispecific Antibody Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Bispecific Antibody Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Bispecific Antibody Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Bispecific Antibody Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Bispecific Antibody Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Bispecific Antibody Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Bispecific Antibody Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Bispecific Antibody Industry Development
Table Global Bispecific Antibody Sales Volume by Player (2017-2022)
Table Global Bispecific Antibody Sales Volume Share by Player (2017-2022)
Figure Global Bispecific Antibody Sales Volume Share by Player in 2021
Table Bispecific Antibody Revenue (Million USD) by Player (2017-2022)
Table Bispecific Antibody Revenue Market Share by Player (2017-2022)
Table Bispecific Antibody Price by Player (2017-2022)
Table Bispecific Antibody Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Bispecific Antibody Sales Volume, Region Wise (2017-2022)
Table Global Bispecific Antibody Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Bispecific Antibody Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Bispecific Antibody Sales Volume Market Share, Region Wise in 2021
Table Global Bispecific Antibody Revenue (Million USD), Region Wise (2017-2022)
Table Global Bispecific Antibody Revenue Market Share, Region Wise (2017-2022)
Figure Global Bispecific Antibody Revenue Market Share, Region Wise (2017-2022)
Figure Global Bispecific Antibody Revenue Market Share, Region Wise in 2021
Table Global Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Bispecific Antibody Sales Volume by Type (2017-2022)
Table Global Bispecific Antibody Sales Volume Market Share by Type (2017-2022)
Figure Global Bispecific Antibody Sales Volume Market Share by Type in 2021
Table Global Bispecific Antibody Revenue (Million USD) by Type (2017-2022)
Table Global Bispecific Antibody Revenue Market Share by Type (2017-2022)
Figure Global Bispecific Antibody Revenue Market Share by Type in 2021
Table Bispecific Antibody Price by Type (2017-2022)
Figure Global Bispecific Antibody Sales Volume and Growth Rate of Mab or Peptide (2017-2022)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of Mab or Peptide (2017-2022)
Figure Global Bispecific Antibody Sales Volume and Growth Rate of BiTE (2017-2022)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of BiTE (2017-2022)
Figure Global Bispecific Antibody Sales Volume and Growth Rate of Bispecific mAb (2017-2022)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of Bispecific mAb (2017-2022)
Figure Global Bispecific Antibody Sales Volume and Growth Rate of CAR-T (2017-2022)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of CAR-T (2017-2022)
Figure Global Bispecific Antibody Sales Volume and Growth Rate of ADC (2017-2022)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of ADC (2017-2022)
Figure Global Bispecific Antibody Sales Volume and Growth Rate of Small Molecule (2017-2022)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of Small Molecule (2017-2022)
Table Global Bispecific Antibody Consumption by Application (2017-2022)
Table Global Bispecific Antibody Consumption Market Share by Application (2017-2022)
Table Global Bispecific Antibody Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Bispecific Antibody Consumption Revenue Market Share by Application (2017-2022)
Table Global Bispecific Antibody Consumption and Growth Rate of Oncology (2017-2022)
Table Global Bispecific Antibody Consumption and Growth Rate of Solid Tumors (2017-2022)
Table Global Bispecific Antibody Consumption and Growth Rate of Inflammation (2017-2022)
Table Global Bispecific Antibody Consumption and Growth Rate of Cardiovascular (2017-2022)
Table Global Bispecific Antibody Consumption and Growth Rate of General Medicine (2017-2022)
Figure Global Bispecific Antibody Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Bispecific Antibody Price and Trend Forecast (2022-2027)
Figure USA Bispecific Antibody Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Bispecific Antibody Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Bispecific Antibody Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Bispecific Antibody Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Bispecific Antibody Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Bispecific Antibody Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Bispecific Antibody Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Bispecific Antibody Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Bispecific Antibody Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Bispecific Antibody Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Bispecific Antibody Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Bispecific Antibody Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Bispecific Antibody Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Bispecific Antibody Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Bispecific Antibody Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Bispecific Antibody Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Bispecific Antibody Market Sales Volume Forecast, by Type
Table Global Bispecific Antibody Sales Volume Market Share Forecast, by Type
Table Global Bispecific Antibody Market Revenue (Million USD) Forecast, by Type
Table Global Bispecific Antibody Revenue Market Share Forecast, by Type
Table Global Bispecific Antibody Price Forecast, by Type
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of Mab or Peptide (2022-2027)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of Mab or Peptide (2022-2027)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of BiTE (2022-2027)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of BiTE (2022-2027)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of Bispecific mAb (2022-2027)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of Bispecific mAb (2022-2027)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of CAR-T (2022-2027)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of CAR-T (2022-2027)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of ADC (2022-2027)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of ADC (2022-2027)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of Small Molecule (2022-2027)
Figure Global Bispecific Antibody Revenue (Million USD) and Growth Rate of Small Molecule (2022-2027)
Table Global Bispecific Antibody Market Consumption Forecast, by Application
Table Global Bispecific Antibody Consumption Market Share Forecast, by Application
Table Global Bispecific Antibody Market Revenue (Million USD) Forecast, by Application
Table Global Bispecific Antibody Revenue Market Share Forecast, by Application
Figure Global Bispecific Antibody Consumption Value (Million USD) and Growth Rate of Oncology (2022-2027)
Figure Global Bispecific Antibody Consumption Value (Million USD) and Growth Rate of Solid Tumors (2022-2027)
Figure Global Bispecific Antibody Consumption Value (Million USD) and Growth Rate of Inflammation (2022-2027)
Figure Global Bispecific Antibody Consumption Value (Million USD) and Growth Rate of Cardiovascular (2022-2027)
Figure Global Bispecific Antibody Consumption Value (Million USD) and Growth Rate of General Medicine (2022-2027)
Figure Bispecific Antibody Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Regeneron Pharmaceuticals Profile
Table Regeneron Pharmaceuticals Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Regeneron Pharmaceuticals Bispecific Antibody Sales Volume and Growth Rate
Figure Regeneron Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Ablynx Profile
Table Ablynx Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ablynx Bispecific Antibody Sales Volume and Growth Rate
Figure Ablynx Revenue (Million USD) Market Share 2017-2022
Table MacroGenics Profile
Table MacroGenics Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure MacroGenics Bispecific Antibody Sales Volume and Growth Rate
Figure MacroGenics Revenue (Million USD) Market Share 2017-2022
Table Neovii Biotech Profile
Table Neovii Biotech Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Neovii Biotech Bispecific Antibody Sales Volume and Growth Rate
Figure Neovii Biotech Revenue (Million USD) Market Share 2017-2022
Table Adimab Profile
Table Adimab Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Adimab Bispecific Antibody Sales Volume and Growth Rate
Figure Adimab Revenue (Million USD) Market Share 2017-2022
Table Sanofi Profile
Table Sanofi Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi Bispecific Antibody Sales Volume and Growth Rate
Figure Sanofi Revenue (Million USD) Market Share 2017-2022
Table Emergent BioSolutions Profile
Table Emergent BioSolutions Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Emergent BioSolutions Bispecific Antibody Sales Volume and Growth Rate
Figure Emergent BioSolutions Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca (MedImmune) Profile
Table AstraZeneca (MedImmune) Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca (MedImmune) Bispecific Antibody Sales Volume and Growth Rate
Figure AstraZeneca (MedImmune) Revenue (Million USD) Market Share 2017-2022
Table NovImmune SA Profile
Table NovImmune SA Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure NovImmune SA Bispecific Antibody Sales Volume and Growth Rate
Figure NovImmune SA Revenue (Million USD) Market Share 2017-2022
Table Immunomedics Profile
Table Immunomedics Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Immunomedics Bispecific Antibody Sales Volume and Growth Rate
Figure Immunomedics Revenue (Million USD) Market Share 2017-2022
Table Roche Profile
Table Roche Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Roche Bispecific Antibody Sales Volume and Growth Rate
Figure Roche Revenue (Million USD) Market Share 2017-2022
Table EMD Serono Profile
Table EMD Serono Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure EMD Serono Bispecific Antibody Sales Volume and Growth Rate
Figure EMD Serono Revenue (Million USD) Market Share 2017-2022
Table Pieris Profile
Table Pieris Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pieris Bispecific Antibody Sales Volume and Growth Rate
Figure Pieris Revenue (Million USD) Market Share 2017-2022
Table OncoMed Pharmaceuticals Profile
Table OncoMed Pharmaceuticals Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure OncoMed Pharmaceuticals Bispecific Antibody Sales Volume and Growth Rate
Figure OncoMed Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Eli Lilly Profile
Table Eli Lilly Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eli Lilly Bispecific Antibody Sales Volume and Growth Rate
Figure Eli Lilly Revenue (Million USD) Market Share 2017-2022
Table Jounce Therapeutics Profile
Table Jounce Therapeutics Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Jounce Therapeutics Bispecific Antibody Sales Volume and Growth Rate
Figure Jounce Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Chugai Pharmaceutical Profile
Table Chugai Pharmaceutical Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Chugai Pharmaceutical Bispecific Antibody Sales Volume and Growth Rate
Figure Chugai Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table Merus Profile
Table Merus Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merus Bispecific Antibody Sales Volume and Growth Rate
Figure Merus Revenue (Million USD) Market Share 2017-2022
Table Genmab Profile
Table Genmab Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Genmab Bispecific Antibody Sales Volume and Growth Rate
Figure Genmab Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Bispecific Antibody Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table Affimed Therapeutics Profile
Table Affimed Therapeutics Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Affimed Therapeutics Bispecific Antibody Sales Volume and Growth Rate
Figure Affimed Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Genentech Profile
Table Genentech Bispecific Antibody Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Genentech Bispecific Antibody Sales Volume and Growth Rate
Figure Genentech Revenue (Million USD) Market Share 2017-2022


More Publications